Colgate-Palmolive is expected to report Q3 2026 revenue of $5.33 billion and earnings per share of $0.92, while the stock currently trades around $93.10 against an average analyst price target of $100.00.
The primary focus for investors is organic sales growth, with markets specifically looking for a volume-led recovery to sustain momentum as global price increases begin to normalize.
While strong performance in Hill’s Pet Nutrition and emerging markets like Latin America and India continues to drive growth, a multi-quarter volume decline in North America remains a point of concern for analysts.
Investors will also monitor whether management's productivity initiatives can offset margin pressure from rising raw material costs, particularly with oil prices recently trending above the company’s reference levels.